IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding IGC Pharma, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 29 | 26 | −3 |
| Shares | 3.27M | 3.05M | −222.9K (−6.8%) |
| Value | $1.73M | $1.31M | −$422.0K (−24.4%) |
New holders (4)
Institutions that held IGC Pharma, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 82,125 | $35.0K | 0.00% |
| Two Sigma Securities, LLC | 37,301 | $16.0K | 0.00% |
| FMR LLC | 300 | $0 | 0.00% |
| Steward Partners Investment Advisory, LLC | 300 | $0 | 0.00% |
Sold out (7)
Institutions that held IGC Pharma, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Davy Global Fund Management Ltd | 102,133 | $54.0K |
| Virtu Financial LLC | 44,970 | $24.0K |
| HRT Financial LP | 19,694 | $10.0K |
| ExodusPoint Capital Management, LP | 13,049 | $7.00K |
| Toronto Dominion Bank | 1,106 | $1.00K |
| Evermay Wealth Management LLC | 30 | $0 |
| Cutler Group LP | 796 | $0 |